NDC Package 59627-003-01 Avonex Pen

Interferon Beta-1a Injection, Solution Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59627-003-01
Package Description:
1 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE
Product Code:
Proprietary Name:
Avonex Pen
Non-Proprietary Name:
Interferon Beta-1a
Substance Name:
Interferon Beta-1a
Usage Information:
This medication is used to treat multiple sclerosis (MS). Interferon is not a cure for MS, but it may help to slow disease worsening and decrease flare-ups of symptoms (such as balance problems, numbness, or weakness).
11-Digit NDC Billing Format:
59627000301
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1650899 - interferon beta-1a 30 MCG in 0.5 ML Auto-Injector
  • RxCUI: 1650899 - 0.5 ML interferon beta-1a 0.06 MG/ML Auto-Injector
  • RxCUI: 1650899 - interferon beta-1a 30 MCG per 0.5 ML Auto-Injector
  • RxCUI: 1650901 - Avonex 30 MCG in 0.5 ML Auto-Injector
  • RxCUI: 1650901 - 0.5 ML interferon beta-1a 0.06 MG/ML Auto-Injector [Avonex]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Biogen Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA103628
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    05-23-2003
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 59627-003-01?

    The NDC Packaged Code 59627-003-01 is assigned to a package of 1 syringe in 1 carton / .5 ml in 1 syringe of Avonex Pen, a human prescription drug labeled by Biogen Inc.. The product's dosage form is injection, solution and is administered via intramuscular form.

    Is NDC 59627-003 included in the NDC Directory?

    Yes, Avonex Pen with product code 59627-003 is active and included in the NDC Directory. The product was first marketed by Biogen Inc. on May 23, 2003 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 59627-003-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 59627-003-01?

    The 11-digit format is 59627000301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-259627-003-015-4-259627-0003-01